REFERENCES
- Haleblain J. K., McCrone W. J. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 1969; 58: 911–929
- Khankari R. K., Grant D. J. W. Pharmaceutical hydrates. Thermochim. Acta 1995; 248: 61–79
- Byrn S. Solid State Chemistry of Drugs. Academic press, New York, NY 1982
- Mosquera M. J., Cal S., Souto C., Concheiro A., Martinez-Pacheco R., Gomez-Amoza J. L. Effects of storage humidity on the mechanical, microstructural, and drug release properties of hydroxypropylmethylcellulose-based hydrophilic matrix tablets. Drug Dev. Ind. Pharm. 1997; 23: 403–406
- Nakagawa H., Takahashi Y., Sugimoto I. The effects of grinding and drying on the solid-state stability of sodium prasterone sulfate. Chem. Pharm. Bull. 1982; 30: 242–248
- Monkhouse D. C., van Campen L. Solid state reactions–theoretical and experimental aspects. Drug Dev. Ind. Pharm. 1984; 10: 1175–1276
- Shalaev E. Y., Shalaeva M., Byrn S. R., Zografi G. Effects of processing on the solid-state methyl transfer of tetraglycine methyl ester. Int. J. Pharm. 1997; 152: 75–88
- Teraoka R., Otsuka M., Matsuda Y. Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride. J. Pharm. Sci. 1993; 82: 601–604
- Phadnis N. V., Suryanarayanan R. Polymorphism in anhydrous theophylline—implications on the dissolution rate of theophylline tablets. J. Pharm. Sci. 1997; 86: 1256–1263
- Tank J. MS Thesis. Changes in the Solid-State of Theophylline upon Aqueous Wet Granulation. University of Minnesota, Minneapolis, MN 1997
- York P. Solid-state properties of powder in the formulation and processing of solid dosage forms. Int. J. Pharm. 1983; 14: 1–28
- Varney M. D., Marzoni G. P., Palmer C. L., Deal J. W., Webber W., Welsh K. M., Bacquet R. J., Morse C. A., Herrmann C. L. Z., Howland E. F., Ward R. W., White J. Crystal-structure based design and synthesis of Benz[cd]indode-containing inhibitors of thymidylate synthase. J. Med. Chem. 1992; 35: 663–667
- Webber S., Bartlett C. A., Boritzki T. J., Hillard J. A., Howland E. F., Johnston A. L., Kosa M., Margosaik S. A., Morse C. A., Shetty B. V. AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. Cancer Chemother. Pharmacol. 1996; 37: 509–517
- Li S., Zamansky I., Orlov I., Tyle P., Roy S. D. Preformulation studies for the development of a parenteral liquid formulation of an antitumor agent, AG337. PDA J. Pharm. Sci. Tech. 1997; 51: 181–186
- , Unpublished data, Agouron Pharmaceutical, Inc.
- Hu M., Roland K., Ge L., Chen J., Li Y., Tyle P., Roy S. Determination of absorption characteristics of AG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model. J. Pharm. Sci. 1998; 87: 886–890
- Dash A. K., Tyle P. Solid-state charactization of AG337 (Thymitaq), a novel antitumor drug. J. Pharm. Sci. 1996; 85: 1123–1127
- Han J., Suryanarayanan R. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate. Pharm. Dev. Tech. 1998; 3: 587–596
- Rastogi S., Zakrzewski M., Suryanarayanan R. Use of high temperature X-ray powder diffractometry (XRD) to investigate complex solid-state reactions. Pharm. Res. 1997; 14(S)192
- Rodriguez C., Bugay D. E. Characterization of pharmaceutical solvates by combined thermogravimetric and infrared analysis. J. Pharm. Sci. 1997; 86: 263–266
- Nyquist R. A., Putzig C. L., Leugers M. A. The Handbook of Infrared and Raman Spectra of Inorganic and Organic Salts. Academic Press, New York 1997
- Craver C. D. Regulated and Major Industrial Chemicals: A Special Collection of Infrared Spectra. The Coblentz Society, Inc., Kirkwood, MO 1983
- Hansen D. L. Sprouse Collection of Infrared Spectra. Sprouse Scientific Systems, Paoli, PA 1990
- Suryanarayanan R., Mitchell A. G. Phase transitions of calcium glueptate. Int. J. Pharm. 1986; 32: 213–221